Fidelity Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Fidelity Investments’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.85B	Sell	6,406,372 -1,320,812	-17%	-$588M	0.16%	94
2025 Q1	$3.75B	Sell	7,727,184 -1,491,862	-16%	-$723M	0.24%	59
2024 Q4	$3.71B	Sell	9,219,046 -1,305,967	-12%	-$526M	0.22%	61
2024 Q3	$4.89B	Sell	10,525,013 -204,415	-2%	-$95.1M	0.3%	45
2024 Q2	$5.03B	Buy	10,729,428 +55,908	+0.5%	+$26.2M	0.32%	40
2024 Q1	$4.46B	Sell	10,673,520 -2,305,991	-18%	-$964M	0.3%	45
2023 Q4	$5.28B	Sell	12,979,511 -1,380,926	-10%	-$562M	0.41%	33
2023 Q3	$4.99B	Sell	14,360,437 -268,229	-2%	-$93.3M	0.43%	34
2023 Q2	$5.15B	Sell	14,628,666 -1,647,189	-10%	-$580M	0.43%	31
2023 Q1	$5.13B	Sell	16,275,855 -1,590,436	-9%	-$501M	0.47%	28
2022 Q4	$5.16B	Buy	17,866,291 +500,268	+3%	+$144M	0.51%	25
2022 Q3	$5.03B	Buy	17,366,023 +613,012	+4%	+$177M	0.52%	24
2022 Q2	$4.72B	Buy	16,753,011 +3,571,298	+27%	+$1.01B	0.47%	28
2022 Q1	$3.44B	Buy	13,181,713 +4,087,860	+45%	+$1.07B	0.27%	52
2021 Q4	$2B	Buy	9,093,853 +4,216,754	+86%	+$926M	0.15%	113
2021 Q3	$885M	Sell	4,877,099 -956,964	-16%	-$174M	0.07%	258
2021 Q2	$1.18B	Sell	5,834,063 -4,337,179	-43%	-$875M	0.09%	196
2021 Q1	$2.19B	Sell	10,171,242 -2,972,684	-23%	-$639M	0.19%	94
2020 Q4	$3.11B	Sell	13,143,926 -6,995,070	-35%	-$1.65B	0.28%	55
2020 Q3	$5.48B	Buy	20,138,996 +868,479	+5%	+$236M	0.55%	24
2020 Q2	$5.59B	Sell	19,270,517 -3,386,072	-15%	-$983M	0.62%	20
2020 Q1	$5.39B	Sell	22,656,589 -1,204,873	-5%	-$287M	0.75%	15
2019 Q4	$5.22B	Sell	23,861,462 -870,552	-4%	-$191M	0.58%	22
2019 Q3	$4.19B	Buy	24,732,014 +32,099	+0.1%	+$5.44M	0.5%	26
2019 Q2	$4.53B	Buy	24,699,915 +265,756	+1%	+$48.7M	0.53%	23
2019 Q1	$4.49B	Buy	24,434,159 +3,951,050	+19%	+$727M	0.54%	25
2018 Q4	$3.39B	Buy	20,483,109 +2,411,631	+13%	+$400M	0.46%	31
2018 Q3	$3.48B	Buy	18,071,478 +1,714,071	+10%	+$330M	0.39%	33
2018 Q2	$2.78B	Sell	16,357,407 -927,665	-5%	-$158M	0.32%	47
2018 Q1	$2.82B	Buy	17,285,072 +553,239	+3%	+$90.2M	0.33%	44
2017 Q4	$2.51B	Buy	16,731,833 +171,388	+1%	+$25.7M	0.29%	52
2017 Q3	$2.52B	Sell	16,560,445 -1,923,268	-10%	-$292M	0.3%	54
2017 Q2	$2.38B	Sell	18,483,713 -380,935	-2%	-$49.1M	0.3%	59
2017 Q1	$2.06B	Sell	18,864,648 -1,232,140	-6%	-$135M	0.26%	69
2016 Q4	$1.48B	Sell	20,096,788 -2,840,955	-12%	-$209M	0.2%	96
2016 Q3	$2B	Buy	22,937,743 +710,639	+3%	+$62M	0.27%	74
2016 Q2	$1.91B	Buy	22,227,104 +7,092,351	+47%	+$610M	0.26%	70
2016 Q1	$1.2B	Buy	15,134,753 +125,568	+0.8%	+$9.98M	0.17%	120
2015 Q4	$1.89B	Sell	15,009,185 -2,679,916	-15%	-$337M	0.25%	73
2015 Q3	$1.84B	Buy	17,689,101 +1,178,706	+7%	+$123M	0.26%	71
2015 Q2	$2.04B	Buy	16,510,395 +1,107,622	+7%	+$137M	0.26%	69
2015 Q1	$1.82B	Buy	15,402,773 +946,619	+7%	+$112M	0.23%	81
2014 Q4	$1.72B	Buy	14,456,154 +435,461	+3%	+$51.7M	0.22%	94
2014 Q3	$1.57B	Buy	14,020,693 +994,150	+8%	+$112M	0.21%	99
2014 Q2	$1.23B	Buy	13,026,543 +6,417,821	+97%	+$608M	0.17%	126
2014 Q1	$467M	Buy	6,608,722 +891,941	+16%	+$63.1M	0.06%	329
2013 Q4	$425M	Sell	5,716,781 -3,311,449	-37%	-$246M	0.06%	348
2013 Q3	$685M	Sell	9,028,230 -634,412	-7%	-$48.1M	0.1%	221
2013 Q2	$772M	Buy	+9,662,642	New	+$772M	0.13%	175